Seroatlas · Human Serome Atlas

PRTN3

Myeloblastin

Also known as: ACPA, AGP7, C-ANCA, MBT, P29, PR-3, PRTN3_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P24158
Gene
PRTN3
Ensembl
ENSG00000196415
Chromosome
19
Canonical length
256 aa
Protein class
Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins
Subcellular location
Vesicles,Cytosol
Secretome location
Secreted to blood

OverviewNCBI Gene

Enables enzyme binding activity; serine-type endopeptidase activity; and signaling receptor binding activity. Involved in several processes, including mature conventional dendritic cell differentiation; neutrophil extravasation; and positive regulation of GTPase activity. Located in azurophil granule lumen; cytosol; and plasma membrane raft. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

256 residues, UniProt reviewed canonical sequence.

>P24158|PRTN3
     1  MAHRPPSPAL ASVLLALLLS GAARAAEIVG GHEAQPHSRP YMASLQMRGN PGSHFCGGTL
    61  IHPSFVLTAA HCLRDIPQRL VNVVLGAHNV RTQEPTQQHF SVAQVFLNNY DAENKLNDVL
   121  LIQLSSPANL SASVATVQLP QQDQPVPHGT QCLAMGWGRV GAHDPPAQVL QELNVTVVTF
   181  FCRPHNICTF VPRRKAGICF GDSGGPLICD GIIQGIDSFV IWGCATRLFP DFFTRVALYV
   241  DWIRSTLRRV EAKGRP

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against PRTN3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
1,978 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 1,978 nTPM
  • spleen: 38 nTPM
  • lung: 12 nTPM
  • thymus: 6.7 nTPM
  • cerebral cortex: 3.6 nTPM
  • liver: 2.7 nTPM

Single-cell type

  • neutrophil progenitors: 339 nCPM
  • monocyte progenitors: 320 nCPM
  • erythrocytes: 5.9 nCPM
  • hematopoietic stem cells: 1 nCPM
  • kupffer cells: 1 nCPM
  • brain excitatory neurons: 0.7 nCPM

Immune cell

  • total PBMC: 9.9 nTPM
  • neutrophil: 2 nTPM
  • gdT-cell: 0.2 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM

Brain region

  • cerebral cortex: 1.4 nTPM
  • basal ganglia: 1.2 nTPM
  • hypothalamus: 0.9 nTPM
  • amygdala: 0.8 nTPM
  • hippocampal formation: 0.6 nTPM
  • midbrain: 0.6 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about PRTN3.

Disease | ImmuneIEDB

Conditions an epitope on PRTN3 was assayed in.

Disease | AutoantibodyPubMed

Conditions in which antibodies against PRTN3 are reported. Each links to that disease's full target list.

Showing 20 of 52 — disease pages carrying at least 10 antigens.

ReferencesPubMed · IEDB

Publications for PRTN3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: AutoantibodyPubMed

552 publications

Show 20 more of 552 total

Reference: T cellIEDB

13 publications

Show 8 more

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.65
gnomAD pLI
0
gnomAD missense Z
0.15
DepMap mean gene effect
-0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of PRTN3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads PRTN3 as an antibody target. Whether an autoantibody or antibody against PRTN3 could matter depends on whether native PRTN3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

PRTN3 is annotated at the cell surface, where native PRTN3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label PRTN3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/PRTN3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...